Current treatments
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. Ahmad I et al. Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.319. [Epub ahead of print]. Phase I/II trial of Weekly Bortezomib with Lenalidomide and Dexamethasone in First Relapse or Primary Refractory Myeloma. Broijl A et al. Haematologica. 2015 Dec 11. pii: haematol.2015.132431. [Epub ahead…
Details